Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer
- All Author(s)
- S. C. Lee
; J. H. Kim
; S. Y. Oh
; K. Kim
; S. Y. Song
; N. Lee
; E. M. I. Nam
; S. Lee
; I. G. Hwang
; H. R. Lee
; J. H. Won
; K. T. Lee
; S. B. Bae
; H. Kim
; H. J. Kim
; J. Jang
; D. H. Lim
; H. W. Lee
; J. H. Kang
- Intsitutional Author(s)
- 이상철; 이규택; 배상병; 김한조
- Issued Date
- 2016
- Type
- Conference
- Conference Name
- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
- Conference Date
- 42524
- dc_citation_conferenceCountry
- Chicago, IL, United States
- Citation Publisher
- American Society of Clinical Oncology
- Citation Title
- Journal of Clinical Oncology. Volume 34, Number 15_suppl
- Citation Start Page
- e15731
- Citation End Page
- e15731
- Language(ISO)
- eng
- DOI
- 10.1200/JCO.2016.34.15_suppl.e15731
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4547
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.